About Hepatitis CHepatitis C is a serious and potentially life-threatening disease. It is the most common blood-borne infection in America and the most common form of liver cancer, the world’s nearly 5 million people in the United States and approximately 170 million people. It is the leading cause of liver cirrhosis and liver cancer, and the number one reason for liver transplants in the United States.
Spiegel, chief medical officer and senior vice president, Schering-Plough Research Institute. With these results we now have, for the first time, offer a large number of well-controlled clinical data that show as the similarities and differences of the two leading combination therapies for the treatment of hepatitis C to influence patient outcomes. These findings are important clinical-based evidence that in in treatment decisions and in the management of of their patients , helping is a long and demanding course of therapy. We are delighted to win on further analysis of this large dataset with additional clinical insight into the management of this devastating disease.. Total adverse events for the three were were reported, and similarly, have as studies with these studies with these were were a number of flu-like symptoms, the most frequently reported adverse events for all three treatment arms. Continue reading